The Business of Biofabrication

Lattice Medical took center stage at the 2024 MedTech Innovator Mid-Stage Grand Prize competition, securing $200,000 in non-dilutive cash proceeds. This recognition not only validates Lattice Medical’s groundbreaking work in breast reconstruction but also spotlights the potential of bioprinting in healthcare.

Lattice Medical breast implant shown above.

The Winning Innovation: MATTISE 3D-Printed Breast Implant

Lattice Medical, based in Loos, France, is innovating in reconstructive surgery with its MATTISE resorbable breast implant. Leveraging advanced 3D bioprinting and innovative biomaterials, the MATTISE implant offers a natural and simplified solution for breast reconstruction after cancer. Unlike traditional implants, it is designed to resorb into the body while promoting the natural regrowth of breast tissue, providing a more holistic and patient-friendly approach to post-mastectomy care.

Why It Matters

Paul Grand, CEO of MedTech Innovator, emphasized that MATTISE could improve breast reconstruction by simplifying surgical procedures and enhancing patient outcomes. This innovation underscores the growing synergy between bioprinting technology and regenerative medicine, where custom-designed implants can adapt to individual patient needs.

For CEO Julien Payen and the Lattice Medical team, this win represents the culmination of seven years of rigorous R&D and collaboration with experts, including the American Plastic Surgery Association. It’s a testament to their dedication to addressing unmet needs in breast reconstruction and scaling access to life-changing solutions.

The Road to the U.S. Market

Winning the Mid-Stage Grand Prize doesn’t just come with financial benefits; it also amplifies Lattice Medical’s visibility in the competitive U.S. healthcare market. The award’s platform will help them navigate the complex regulatory landscape and connect with strategic partners, investors, and stakeholders eager to support their entry into the world’s largest medtech market.

What Sets Lattice Medical Apart

Lattice Medical is part of a broader movement of mid-stage companies leveraging bioprinting to solve real-world medical challenges. The MATTISE implant exemplifies the convergence of:

• Precision bioprinting: Tailored designs to match individual anatomical needs.
• Resorbable biomaterials: Offering biocompatibility and eliminating the need for future removal surgeries.
• Patient-centric innovation: Simplifying the reconstruction process while promoting natural tissue regeneration.

Their success highlights the evolving role of bioprinting in medtech, where innovation meets patient empowerment.

Lattice Medical’s victory at the MedTech Innovator competition marks a moment for bioprinting in healthcare. By addressing a critical need with novel technology, they exemplify the impact that bioprinting can have on patient care. As they gear up for U.S. market entry, their journey serves as a beacon of what’s possible when innovation meets perseverance.

About Lattice Medical

Lattice Medical is a French medtech innovator revolutionizing breast reconstruction with its groundbreaking MATTISE 3D-printed, resorbable breast implant. Designed to promote natural tissue regrowth, the implant offers a patient-friendly alternative to traditional methods by simplifying procedures and eliminating the need for follow-up removal surgeries. With over seven years of R&D and collaboration with leading experts, Lattice Medical is at the forefront of bioprinting solutions, paving the way for more accessible and natural options in reconstructive surgery.

Original article can be found here.